Stereotaxis (STXS) Non-Current Assets (2010 - 2026)
Stereotaxis (STXS) posted quarterly Non-Current Assets of $18.0 million for Q1 2026, down 9.04% year-over-year from $19.8 million in Q1 2025, and down 2.17% quarter-over-quarter from $18.4 million in Q4 2025.
Stereotaxis (STXS) Non-Current Assets (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Non-Current Assets for 17 consecutive years, with $18.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 9.04% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $74.6 million (up 6.35% YoY), while the FY2025 annual figure was $18.4 million, down 9.28% from the prior year.
- Non-Current Assets fell to $18.0 million in Q1 2026 per STXS's latest filing, from $18.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $22.1 million in Q3 2024 and bottomed at $7.9 million in Q2 2024.
- Historically, Non-Current Assets has averaged $13.6 million across 5 years, with a median of $10.2 million in 2022.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 377.76% — and 2024, when it retreated 15.93%.
- Stereotaxis' Non-Current Assets stood at $10.2 million in 2022, then slipped by 15.0% to $8.6 million in 2023, then surged by 134.73% to $20.3 million in 2024, then retreated by 9.28% to $18.4 million in 2025, then fell by 2.17% to $18.0 million in 2026.
- Business Quant data shows STXS's Non-Current Assets at $18.0 million in Q1 2026, $18.4 million in Q4 2025, and $18.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | 18.92 Mn |
| Jun 30, 2025 | 19.27 Mn |
| Mar 31, 2025 | 19.79 Mn |
| Dec 31, 2024 | 20.29 Mn |
| Sep 30, 2024 | 22.12 Mn |
| Jun 30, 2024 | 7.94 Mn |
| Mar 31, 2024 | 8.24 Mn |
| Dec 31, 2023 | 8.64 Mn |
| Sep 30, 2023 | 9.01 Mn |
| Jun 30, 2023 | 9.41 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Dec 31, 2022 | 10.17 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 10.04 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 8.51 Mn |
| Jun 30, 2021 | 2.10 Mn |